Compounds > paclitaxel
Page last updated: 2024-08-23

paclitaxel and Pleural Effusion, Malignant

paclitaxel has been researched along with Pleural Effusion, Malignant in 31 studies

Research

Studies (31)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (12.90)18.2507
2000's15 (48.39)29.6817
2010's12 (38.71)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bergzoll, C; Eva, L; Jamieson, A; Simcock, B; Sykes, P1
Fang, Z; Wang, Z; Zheng, Y1
Asami, K; Atagi, S; Hirashima, T; Kawaguchi, T; Kawase, I; Morishita, N; Nakao, K; Okamoto, N; Okishio, K; Otsuka, T; Shiroyama, T; Suzuki, H; Tamiya, A; Tamiya, M; Yamadori, T; Yasue, T1
Briones-Gómez, A; Cases-Viedma, E; Martínez-Tomás, R; Modesto-Alapont, M; Muñoz-Moya, MA1
Atagi, S; Hamaguchi, M; Hirashima, T; Kawaguchi, T; Morishita, N; Nakao, K; Okamoto, N; Okishio, K; Omachi, N; Shiroyama, T; Suzuki, H; Tamiya, A; Tamiya, M; Tani, E; Yasue, T1
Lai, FC; Li, X; Lin, JB; Lin, JW; Lin, M; Liu, B; Luo, RG; Qiu, ML; Tu, YR1
Du, N; Kang, H; Li, F; Li, X; Qi, N; Zhao, H1
Hosaka, M; Mitamura, T; Sakuragi, N; Takeda, M; Watari, H1
Chew, I; Park, KJ; Soslow, RA1
Chen, L; Lu, Y; Wang, X; Wang, Y; Wei, Y; Zhou, J; Zhu, Z1
Chen, L; Wang, X; Wei, Y; Zheng, H; Zhu, Z1
Abbruzzi, A; Bromberg, J; Chang, J; D'Andrea, G; Dang, C; Dickler, M; Fornier, MN; Gilewski, T; Hudis, CA; Modi, S; Morris, PG; Norton, L; Seidman, AD; Sklarin, N1
Dalla Palma, M; Donach, M; Fiduccia, P; Fiore, D; Gusella, M; Lombardi, G; Nicoletto, MO; Zagonel, V; Zuin, A1
Hachiya, T; Hama, M; Komatsu, Y1
An, J; Fisher, M; Rettig, MB; Sun, Y1
Aiba, K; Hagino, T; Hirano, A; Kawase, K; Kobayashi, M; Kobayashi, T; Okawa, Y; Shioya, H; Sugiyama, K; Uno, S; Usui, N; Yoshida, K1
Akedo, I; Kubo, M; Mori, M; Nakagawa, C; Nishida, Y; Ono, H; Sakai, K; Takeda, E; Tamura, K; Tsugawa, M; Yanagi, K1
Duivenvoorden, W; Matthews, D; Richard, C; Th'ng, JP; Wright, PS; Yau, J1
Endo, W; Fukunaga, H; Hojo, S; Maeura, Y; Ota, H; Yamazaki, K; Yoshioka, S1
Matsumoto, I; Ohta, Y; Shimizu, Y; Watanabe, G1
Duivenvoorden, WC; Richard, C; Th'ng, JP; Yau, J1
Suzuki, M1
Aoki, D; Banno, K; Hirao, N; Kawaguchi, M; Kuwabara, Y; Susumu, N; Tsukazaki, K; Yamagami, W; Yanokura, M1
Maxwell, GL; McGuire, WP; Muggia, F; Rose, GS; Rose, PG; Rubin, SC; Sundborg, MJ; Tian, C; Winter, WE1
Chen, YM; Lin, JY; Lin, SY; Perng, RP; Whang-Peng, J; Wu, MF1
Chen, YM; Chou, KC; Lin, WC; Liu, JM; Perng, RP; Whang-Peng, J; Wu, MF1
Asaoka, K; Ishitani, K; Iwasaki, K; Komuro, Y; Masumoto, N1
Funahashi, H; Hayashi, H; Imai, T; Itoh, T; Kikumori, T; Mase, T; Oiwa, M; Sekiya, M; Shibata, A1
Ashizawa, T; Katayanagi, S; Katsumata, K; Koyanagi, Y; Kusama, M; Murohashi, T; Sumi, T; Yamamoto, K1
Hanta, I; Hasturk, S; Soylu, M; Zeren, EH1
Hazama, K; Kagisaki, K; Matsuda, H; Miyoshi, S; Ohta, M; Shintani, Y1

Reviews

1 review(s) available for paclitaxel and Pleural Effusion, Malignant

ArticleYear
Thymic carcinoma successfully resected with superior vena cava after chemoradiotherapy.
    The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi, 2001, Volume: 49, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Female; Humans; Middle Aged; Paclitaxel; Pericardial Effusion; Pleural Effusion, Malignant; Taxoids; Thymus Neoplasms; Vena Cava, Superior

2001

Trials

7 trial(s) available for paclitaxel and Pleural Effusion, Malignant

ArticleYear
Phase2 study of bevacizumab with carboplatin-paclitaxel for non-small cell lung cancer with malignant pleural effusion.
    Medical oncology (Northwood, London, England), 2013, Volume: 30, Issue:3

    Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma, Non-Small-Cell Lung; Disease Progression; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Pleural Effusion, Malignant; Survival Rate; Treatment Outcome; Vascular Endothelial Growth Factor A

2013
Sequential treatment strategy for malignant pleural effusion in non-small cell lung cancer with the activated epithelial grow factor receptor mutation.
    Journal of drug targeting, 2017, Volume: 25, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Female; Gefitinib; Humans; Male; Middle Aged; Mutation; Paclitaxel; Pleural Effusion, Malignant; Quinazolines

2017
A phase I clinical and pharmacokinetic study of paclitaxel liposome infused in non-small cell lung cancer patients with malignant pleural effusions.
    European journal of cancer (Oxford, England : 1990), 2010, Volume: 46, Issue:8

    Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Dose-Response Relationship, Drug; Feasibility Studies; Female; Humans; Liposomes; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Pleural Effusion, Malignant; Treatment Outcome

2010
A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2011, Volume: 22, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Breast Neoplasms, Male; Dasatinib; Edema; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Paclitaxel; Pleural Effusion, Malignant; Pyrimidines; Thiazoles; Treatment Outcome

2011
Intrapleural paclitaxel for malignant pleural effusion from ovarian and breast cancer: a phase II study with pharmacokinetic analysis.
    Cancer chemotherapy and pharmacology, 2012, Volume: 69, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Disease-Free Survival; Dose-Response Relationship, Drug; Drainage; Female; Humans; Instillation, Drug; Middle Aged; Ovarian Neoplasms; Paclitaxel; Pleural Cavity; Pleural Effusion, Malignant; Tissue Distribution

2012
A phase I feasibility and pharmacokinetic study of intrapleural paclitaxel in patients with malignant pleural effusions.
    Anti-cancer drugs, 1997, Volume: 8, Issue:6

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Dose-Response Relationship, Drug; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Paclitaxel; Pleural Effusion, Malignant; Treatment Outcome; Vomiting

1997
Phase II trial of intrapleural paclitaxel injection for non-small-cell lung cancer patients with malignant pleural effusions.
    Respiratory medicine, 1998, Volume: 92, Issue:3

    Topics: Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Drainage; Female; Humans; Injections; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Pleural Effusion, Malignant; Treatment Outcome

1998

Other Studies

23 other study(ies) available for paclitaxel and Pleural Effusion, Malignant

ArticleYear
Subtypes of stage IV ovarian cancer; response to treatment and patterns of disease recurrence.
    Gynecologic oncology, 2017, Volume: 146, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Ovarian Epithelial; Chemotherapy, Adjuvant; Cytoreduction Surgical Procedures; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Cystic, Mucinous, and Serous; Neoplasms, Glandular and Epithelial; New Zealand; Ovarian Neoplasms; Paclitaxel; Pleural Effusion, Malignant; Prognosis; Retrospective Studies; Treatment Outcome

2017
The clinical efficacy and safety of paclitaxel combined with avastin for NSCLC patients diagnosed with malignant pleural effusion.
    Revista da Associacao Medica Brasileira (1992), 2018, Volume: 64, Issue:3

    Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Pleural Effusion, Malignant; Quality of Life; Safety; Survival Analysis; Treatment Outcome

2018
Insertion of a metallic guide-wire in the pleural cavity as a complication in tunneled indwelling pleural catheter placement.
    Archivos de bronconeumologia, 2015, Volume: 51, Issue:4

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Catheters, Indwelling; Foreign Bodies; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Palliative Care; Pleural Cavity; Pleural Effusion, Malignant; Thoracentesis

2015
Vascular Endothelial Growth Factor in Plasma and Pleural Effusion Is a Biomarker for Outcome After Bevacizumab plus Carboplatin-Paclitaxel Treatment for Non-small Cell Lung Cancer with Malignant Pleural Effusion.
    Anticancer research, 2016, Volume: 36, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Non-Small-Cell Lung; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Pleural Effusion; Pleural Effusion, Malignant; Vascular Endothelial Growth Factor A

2016
Combination use of paclitaxel and avastin enhances treatment effect for the NSCLC patients with malignant pleural effusion.
    Medicine, 2016, Volume: 95, Issue:47

    Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Bevacizumab; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Pleural Effusion, Malignant; Survival Rate; Treatment Outcome; Vascular Endothelial Growth Factor A

2016
Intrathoracic injection of paclitaxel for a patient with stage IV serous ovarian cancer: a case report.
    Cancer chemotherapy and pharmacology, 2009, Volume: 64, Issue:1

    Topics: Aged; Antineoplastic Agents, Phytogenic; Chemotherapy, Adjuvant; Cystadenocarcinoma, Serous; Female; Humans; Injections; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Pleural Effusion, Malignant; Thorax; Time Factors

2009
Morphologic changes in ovarian carcinoma after neoadjuvant chemotherapy: report of a case showing extensive clear cell changes mimicking clear cell carcinoma.
    International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists, 2009, Volume: 28, Issue:5

    Topics: Adenocarcinoma, Clear Cell; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Cystadenocarcinoma, Serous; Diagnosis, Differential; Female; Humans; Hypercholesterolemia; Hypertension; Immunohistochemistry; Neoadjuvant Therapy; Ovarian Neoplasms; Paclitaxel; Pleural Effusion, Malignant

2009
Clinical pharmacokinetics of paclitaxel liposome with a new route of administration in human based on the analysis with ultra performance liquid chromatography.
    Journal of pharmaceutical sciences, 2010, Volume: 99, Issue:11

    Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Chromatography, High Pressure Liquid; Drug Administration Routes; Humans; Linear Models; Liposomes; Middle Aged; Paclitaxel; Pleural Cavity; Pleural Effusion, Malignant; Sensitivity and Specificity

2010
[A case of lung cancer showing marked reduction of pleural effusion by bevacizumab in combination with carboplatin and paclitaxel].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:11

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Pleural Effusion, Malignant; Tomography, X-Ray Computed

2011
Antitumor effects of bortezomib (PS-341) on primary effusion lymphomas.
    Leukemia, 2004, Volume: 18, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Boronic Acids; Bortezomib; Cell Division; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Drug Synergism; Humans; Lymphoma; Membrane Glycoproteins; NF-kappa B; Paclitaxel; Pleural Effusion, Malignant; Pyrazines; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha

2004
Successful combination therapy with trastuzumab and Paclitaxel for adriamycin- and docetaxel-resistant inflammatory breast cancer.
    Breast cancer (Tokyo, Japan), 2004, Volume: 11, Issue:3

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Docetaxel; Doxorubicin; Female; Humans; Leukopenia; Middle Aged; Neoplasm Staging; Paclitaxel; Pleural Effusion, Malignant; Taxoids; Trastuzumab; Treatment Outcome

2004
[A case of non-small cell lung carcinoma successfully treated with carboplatin and weekly paclitaxel under renal dysfunction].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:12

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chronic Disease; Drug Administration Schedule; Humans; Lung Neoplasms; Male; Nephritis; Paclitaxel; Pleural Effusion, Malignant; Renal Insufficiency

2004
Flavopiridol sensitivity of cancer cells isolated from ascites and pleural fluids.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, May-01, Volume: 11, Issue:9

    Topics: Antineoplastic Agents; Ascites; Blotting, Western; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cisplatin; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Doxorubicin; Flavonoids; Humans; Neoplasms; Paclitaxel; Piperidines; Pleural Effusion, Malignant; Proto-Oncogene Proteins c-bcl-2; Time Factors; Tumor Cells, Cultured

2005
[Two patients of recurrent breast cancer with carcinomatous pleurisy well controlled pleural effusion].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:11

    Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drainage; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Picibanil; Pleural Effusion, Malignant; Pleurisy

2005
Management of malignant pleural effusion by multimodality treatment including the use of paclitaxel administered by 24-hour intrathoracic infusion for patients with carcinomatous pleuritis.
    Journal of experimental & clinical cancer research : CR, 2006, Volume: 25, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Chemotherapy, Cancer, Regional Perfusion; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Paclitaxel; Pleural Effusion; Pleural Effusion, Malignant; Pleural Neoplasms; Pleurisy; Time Factors; Treatment Outcome

2006
Naturally occurring resistance of bone marrow mononuclear and metastatic cancer cells to anticancer agents.
    Clinical & experimental metastasis, 2006, Volume: 23, Issue:5-6

    Topics: Antineoplastic Agents; Ascitic Fluid; Bone Marrow Cells; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Female; Formazans; Humans; Inhibitory Concentration 50; Male; Neoplasm Metastasis; Neoplasms; Neoplastic Stem Cells; Paclitaxel; Pleural Effusion, Malignant; Tetrazolium Salts

2006
[A patient with advanced breast cancer refractory to chemotherapy accompanied by carcinomatous pleurisy and multiple bone metastasis that responded to combination therapy with high-dose toremifene and docetaxel].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:1

    Topics: Aged; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Docetaxel; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Paclitaxel; Pleural Effusion, Malignant; Pleural Neoplasms; Quality of Life; Remission Induction; Taxoids; Toremifene

2007
Use of the collagen gel droplet embedded drug sensitivity test to determine drug sensitivity against ovarian mature cystic teratoma with malignant transformation to adenocarcinoma: a case report.
    Chemotherapy, 2007, Volume: 53, Issue:2

    Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Collagen Type I; Drug Screening Assays, Antitumor; Female; Gels; Humans; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Pleural Effusion, Malignant; Teratoma

2007
Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Jan-01, Volume: 26, Issue:1

    Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Endometrioid; Cisplatin; Cystadenocarcinoma, Serous; Female; Follow-Up Studies; Humans; Medical Records; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Ovarian Neoplasms; Paclitaxel; Pleural Effusion, Malignant; Postoperative Complications; Prognosis; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Rate

2008
[A case of advanced ovarian clear cell adenocarcinoma responding to cisplatin-cyclophosphamide and paclitaxel-carboplatin].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:10

    Topics: Adenocarcinoma, Clear Cell; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Female; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Pleural Effusion, Malignant; Remission Induction

1999
[Administration of docetaxel in cases of recurrent breast carcinoma with malignant pleural effusion controlled by intrapleural administration of OK-432].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:13

    Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Picibanil; Pleura; Pleural Effusion, Malignant; Taxoids

1999
[Recurrent breast cancer successfully treated with a weekly dose of paclitaxel--a case report].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:1

    Topics: Antineoplastic Agents, Phytogenic; Axilla; Breast Neoplasms; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Hydrothorax; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Paclitaxel; Pleural Effusion, Malignant

2001
Basaloid large cell lung carcinoma presenting concurrently with metastatic uveal tumor.
    Lung cancer (Amsterdam, Netherlands), 2001, Volume: 32, Issue:1

    Topics: Carboplatin; Carcinoma, Large Cell; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Paclitaxel; Pleural Effusion, Malignant; Radionuclide Imaging; Smoking; Tomography; Uveal Neoplasms

2001